GarySLedleyMD
Cardiology • Philadelphia, PAAdult Congenital Heart Disease, Interventional Cardiology
Professor, Medicine, Drexel College of Medicine/Hahnemann School of Medicine
Dr. Ledley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5501 Old York Rd
Levy 3210
Philadelphia, PA 19141Phone+1 215-456-7022Fax+1 215-456-3939
Education & Training
Brown UniversityFellowship, Cardiovascular Disease, 1989 - 1990
MedStar Health/Georgetown-Washington Hospital CenterFellowship, Cardiovascular Disease, 1985 - 1989- MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1982 - 1985
Georgetown University School of MedicineClass of 1982
Certifications & Licensure
PA State Medical License 1990 - 2024
VA State Medical License 1984 - 2014
MD State Medical License 1985 - 1990
RI State Medical License 1989 - 1990- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 150 citationsUltrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial.Michel Azizi, Kintur Sanghvi, Manish Saxena, Philippe Gosse, John P. Reilly
Lancet. 2021-06-26 - 79 citationsSix-Month Results of Treatment-Blinded Medication Titration for Hypertension Control After Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedu...Michel Azizi, Roland E. Schmieder, Felix Mahfoud, Michael A. Weber, Joost Daemen
Circulation. 2019-05-28 - 426 citationsEndovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trialMichel Azizi, Roland E. Schmieder, Felix Mahfoud, Michael A. Weber, Joost Daemen
Lancet. 2018-06-09
Press Mentions
Key Interventional Cardiology Takeaways from the SCAI 2022 ConferenceJune 7th, 2022- Walloped by COVID-19, US Cardiology Practices Brace for Slow RecoveryJuly 29th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
